Anticipating an earlier than ideal point along the drug approval path and the use of not fully validated surrogate end points in nonrandomised trials looks like a dangerous shortcut that might jeopardise consumers' health, leading to unsafe and ineffective drugs being marketed and prescribed.
The regulatory approval path for probiotic foods is complicated, particularly going through the FDA.
The guidance document details the requirements for 510(k) submissions — the abbreviated FDA approval path based on preexisting devices — for systems that only highlight suspicious masses scans.
The guidance document details the requirements for 510(k) submissions — the abbreviated FDA approval path based on preexisting devices — for systems that only highlight suspicious masses scans.
A single-analyte assay has several advantages including simpler method development, quantitation, and an easier regulatory approval path.
Thus, manufacturing processes and regulatory approval paths need to be established for each OV individually.
Actually, some people think that the FDA has already started down this path with the approval of Sarepta's Duchenne muscular dystrophy drug, eteplirsen, a drug with very limited extant clinical data in its New Drug Application (NDA).
Leading up to passage of the landmark 2010 legislation creating a regulatory path for the approval of biosimilars (the Biologics Price Competition and Innovation Act), both proponents of such a policy and its critics seemed to coalesce around one point in support of the law.
While hindsight imposed a sequence on the approval process, at the time the path to implementation was not well-defined.
